Rigel Pharmaceuticals Inc (RIGL)
16.44
-0.71
(-4.14%)
USD |
NASDAQ |
Dec 24, 16:00
Rigel Pharmaceuticals Market Cap: 289.59M for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 2.638M |
Palatin Technologies Inc | 19.35M |
iBio Inc | 22.10M |
Theriva Biologics Inc | 4.897M |
Oragenics Inc | 4.616M |
Market Cap Related Metrics
PE Ratio | 71.48 |
PS Ratio | 1.831 |
Price to Free Cash Flow | 27.84 |
Price | 16.44 |
Earnings Yield | 1.40% |
Operating PE Ratio | 30.34 |
Normalized PE Ratio | 71.48 |